MESSAGE from Renown Institute for Cancer Leadership
A YEAR OF ACTIVE CHANGE
This year, 2016, has been a year of implementation. The new leadership structure that came in 2015 led to many new programs in 2016, including:
• $ 8.5M expansion of the Radiation Treatment center, including an improved patient-friendly environment and two new state-of-the-art linear accelerators to provide the most advanced radiation therapy in the region
• Collaborative agreement with community medical oncologists to increase clinical integration and patient coordination.
• Expansion of medical oncology, in preparation for future multidisciplinary centers.
• Expansion of nurse navigation and supportive care programs to enhance the coordination of care.
• Implementation of the first in the region Centers for Medicare & Medicaid Services( CMS) approved Lung Cancer Screening Program, assuring access to high risk patients including an on-site shared decision making clinic.
• Enhancement of the Lung Nodule Clinic with Medical Director, Christina Szot, MD.
• New lung diagnostics, including SuperD, advanced technology that allows the physician to reach distant sites in the lung for biopsies.
• Host for northern Nevada’ s participation in Vice President Joseph Biden’ s Cancer Moonshot project.
• Expansion of medical oncology outreach, including additional telemedicine sites and outreach clinics.
• Opening of the Cardio-Oncology Program with Christopher Wilson, MD, cardiologist.
This Annual Report provides details of some of these enhancements to our program, and more. The Cancer Registry data also provides information about the cancers we diagnose and treat, along with our Quality Report to include a detailed summary of lung cancer at Renown Institute for Cancer.
Respectfully,
Christos Galanopoulos, MD, MBA, MS, FACS Renown Health VP and Chief Clinical Officer, Renown Institute for Cancer
Jo Duszkiewicz, MSA Renown Health VP and Administrator, Renown Institute for Cancer
3